AI Model Stratifies Late Recurrence Risk in HR-Positive Breast Cancer

https://www.profitableratecpm.com/f4ffsdxe?key=39b1ebce72f3758345b2155c98e6709c
(MedPage Today) — At the San Antonio Breast Cancer Symposium, researchers presented their results on Clarity BCR, a multi-modal, multi-task deep learning algorithm that aims to estimate the risk of distant late recurrence in the hormone receptor (HR)-positive breast…




